Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Mul

Aryeh Fischer; Mary E. Strek; Vincent Cottin; Paul F. Dellaripa; Elana J. Bernstein; Kevin K. Brown; Sonye K. Danoff; Oliver Distler; Nik Hirani; Kirk D. Jones; Dinesh Khanna; Joyce S. Lee; David A. Lynch; Toby M. Maher; Ann B. Millar; Ganesh Raghu; Richard M. Silver; Virginia D. Steen; Elizabeth R. Volkmann; Ronan H. Mullan; David N. O'Dwyer; Seamas C. Donnelly

doi:10.1093/qjmed/hcy272

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Mul

Aryeh Fischer^*, Mary E. Strek, Vincent Cottin, Paul F. Dellaripa, Elana J. Bernstein, Kevin K. Brown, Sonye K. Danoff, Oliver Distler, Nik Hirani, Kirk D. Jones, Dinesh Khanna, Joyce S. Lee, David A. Lynch, Toby M. Maher, Ann B. Millar, Ganesh Raghu, Richard M. Silver, Virginia D. Steen, Elizabeth R. Volkmann, Ronan H. MullanDavid N. O'Dwyer, Seamas C. Donnelly

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

This document summarizes the proceedings of a recent summit on CTD-associated ILD attended by a multidisciplinary panel of international clinician-scientists with expertise in CTDassociated ILD. Key clinical aspects are outlined, and a variety of research initiatives are proposed (Table 4) with the aim of addressing the many unmet needs and challenges within the complex intersection between CTD and ILD. Our hope is that further multidisciplinary collaboration around the research into and care of patients with CTD-associated ILD will lead to greater disease awareness, earlier disease detection and diagnosis, implementation of interdisciplinary treatment approaches with novel therapeutic agents, and, ultimately, improved quality of life and outcomes for those who are affected by these diseases.

Original language	English
Pages (from-to)	81-93
Number of pages	13
Journal	QJM
Volume	112
Issue number	2
Early online date	3 Jan 2019
DOIs	https://doi.org/10.1093/qjmed/hcy272
Publication status	Published - 1 Feb 2019

Access to Document

10.1093/qjmed/hcy272

Cite this

Fischer, A., Strek, M. E., Cottin, V., Dellaripa, P. F., Bernstein, E. J., Brown, K. K., Danoff, S. K., Distler, O., Hirani, N., Jones, K. D., Khanna, D., Lee, J. S., Lynch, D. A., Maher, T. M., Millar, A. B., Raghu, G., Silver, R. M., Steen, V. D., Volkmann, E. R., ... Donnelly, S. C. (2019). Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Mul. QJM, 112(2), 81-93. https://doi.org/10.1093/qjmed/hcy272

@article{0e76f0d293004f7f9e17f227e9e97a85,

title = "Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Mul",

abstract = "This document summarizes the proceedings of a recent summit on CTD-associated ILD attended by a multidisciplinary panel of international clinician-scientists with expertise in CTDassociated ILD. Key clinical aspects are outlined, and a variety of research initiatives are proposed (Table 4) with the aim of addressing the many unmet needs and challenges within the complex intersection between CTD and ILD. Our hope is that further multidisciplinary collaboration around the research into and care of patients with CTD-associated ILD will lead to greater disease awareness, earlier disease detection and diagnosis, implementation of interdisciplinary treatment approaches with novel therapeutic agents, and, ultimately, improved quality of life and outcomes for those who are affected by these diseases.",

author = "Aryeh Fischer and Strek, {Mary E.} and Vincent Cottin and Dellaripa, {Paul F.} and Bernstein, {Elana J.} and Brown, {Kevin K.} and Danoff, {Sonye K.} and Oliver Distler and Nik Hirani and Jones, {Kirk D.} and Dinesh Khanna and Lee, {Joyce S.} and Lynch, {David A.} and Maher, {Toby M.} and Millar, {Ann B.} and Ganesh Raghu and Silver, {Richard M.} and Steen, {Virginia D.} and Volkmann, {Elizabeth R.} and Mullan, {Ronan H.} and O'Dwyer, {David N.} and Donnelly, {Seamas C.}",

year = "2019",

month = feb,

day = "1",

doi = "10.1093/qjmed/hcy272",

language = "English",

volume = "112",

pages = "81--93",

journal = "QJM",

issn = "1460-2725",

publisher = "Oxford University Press",

number = "2",

}

Fischer, A, Strek, ME, Cottin, V, Dellaripa, PF, Bernstein, EJ, Brown, KK, Danoff, SK, Distler, O, Hirani, N, Jones, KD, Khanna, D, Lee, JS, Lynch, DA, Maher, TM, Millar, AB, Raghu, G, Silver, RM, Steen, VD, Volkmann, ER, Mullan, RH, O'Dwyer, DN & Donnelly, SC 2019, 'Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Mul', QJM, vol. 112, no. 2, pp. 81-93. https://doi.org/10.1093/qjmed/hcy272

TY - JOUR

T1 - Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit

T2 - A Mul

AU - Fischer, Aryeh

AU - Strek, Mary E.

AU - Cottin, Vincent

AU - Dellaripa, Paul F.

AU - Bernstein, Elana J.

AU - Brown, Kevin K.

AU - Danoff, Sonye K.

AU - Distler, Oliver

AU - Hirani, Nik

AU - Jones, Kirk D.

AU - Khanna, Dinesh

AU - Lee, Joyce S.

AU - Lynch, David A.

AU - Maher, Toby M.

AU - Millar, Ann B.

AU - Raghu, Ganesh

AU - Silver, Richard M.

AU - Steen, Virginia D.

AU - Volkmann, Elizabeth R.

AU - Mullan, Ronan H.

AU - O'Dwyer, David N.

AU - Donnelly, Seamas C.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - This document summarizes the proceedings of a recent summit on CTD-associated ILD attended by a multidisciplinary panel of international clinician-scientists with expertise in CTDassociated ILD. Key clinical aspects are outlined, and a variety of research initiatives are proposed (Table 4) with the aim of addressing the many unmet needs and challenges within the complex intersection between CTD and ILD. Our hope is that further multidisciplinary collaboration around the research into and care of patients with CTD-associated ILD will lead to greater disease awareness, earlier disease detection and diagnosis, implementation of interdisciplinary treatment approaches with novel therapeutic agents, and, ultimately, improved quality of life and outcomes for those who are affected by these diseases.

AB - This document summarizes the proceedings of a recent summit on CTD-associated ILD attended by a multidisciplinary panel of international clinician-scientists with expertise in CTDassociated ILD. Key clinical aspects are outlined, and a variety of research initiatives are proposed (Table 4) with the aim of addressing the many unmet needs and challenges within the complex intersection between CTD and ILD. Our hope is that further multidisciplinary collaboration around the research into and care of patients with CTD-associated ILD will lead to greater disease awareness, earlier disease detection and diagnosis, implementation of interdisciplinary treatment approaches with novel therapeutic agents, and, ultimately, improved quality of life and outcomes for those who are affected by these diseases.

UR - http://www.scopus.com/inward/record.url?scp=85060786666&partnerID=8YFLogxK

U2 - 10.1093/qjmed/hcy272

DO - 10.1093/qjmed/hcy272

M3 - Article

C2 - 30605544

AN - SCOPUS:85060786666

SN - 1460-2725

VL - 112

SP - 81

EP - 93

JO - QJM

JF - QJM

IS - 2

ER -

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Mul

Abstract / Description of output

Access to Document

Other files and links

Fingerprint

Cite this